Article Text

PDF
Heart failure and cardiomyopathy
NHS heart failure survey: a survey of acute heart failure admissions in England, Wales and Northern Ireland
  1. E D Nicol1,2,
  2. B Fittall1,
  3. M Roughton2,
  4. J G F Cleland3,6,
  5. H Dargie4,6,
  6. M R Cowie5,6
  1. 1
    Healthcare Commission, London, UK
  2. 2
    Royal Brompton Hospital, London, UK
  3. 3
    University of Hull, Kingston-upon-Hull, UK
  4. 4
    Cardiac Department, Western Infirmary, Glasgow, UK
  5. 5
    National Heart and Lung Institute, Imperial College, London, UK
  6. 6
    British Society for Heart Failure, British Cardiovascular Society, London UK
  1. Dr E D Nicol, Healthcare Commission, Finsbury Tower, 103–105 Bunhill Row, London EC1Y 8TG, UK; e.nicol{at}rbht.nhs.uk

Abstract

Objectives: To obtain national data on demographics, investigation, treatment and short-term outcome for patients admitted with acute heart failure.

Design: Retrospective survey of emergency admissions with acute heart failure from October 2005 to March 2006.

Setting: Acute NHS trusts in England, Wales and Northern Ireland.

Main outcome measures: Patient demographics, referral source, admission characteristics, admission pathway, patient heart failure treatment on admission, length of stay, short-term mortality, discharge heart failure treatment, specialist follow-up and delayed discharge.

Results: 176/177 (99%) acute trusts responded and 9387 records were surveyed. Patients mean age was 77 (SD 11) years, 50% were women and 56% had prior history of heart failure. On average, women were 5 years older than men (80 vs 75 years, p<0.001), were less likely to have had echocardiography (52% vs 60%, p<0.001), and if previously diagnosed with heart failure less likely to be treated with ACE inhibitors (58.3% vs 66.8%, p<0.001), β-blockers (30.1% vs 35.5%, p = 0.033) or aldosterone antagonists (18.9% vs 22.5%, p<0.001) at admission. In-hospital mortality was 15%. Age-adjusted mortality was higher in men (16% vs 14%, p = 0.042). 75% of patients were admitted with moderate to severe symptoms (NYHA class III or IV). Women were less likely to be prescribed anti-failure medication, except diuretics, on discharge (ACE-I/AIIRA 66.5% vs 73.4%, β-blocker 31.3% vs 37.5%, aldosterone antagonists 23.4% vs 30.1%, all p<0.001). Only 20% of patients had planned specialist heart failure follow-up, with <1% referred for rehabilitation or specialist palliative care.

Conclusion: Many patients admitted to acute hospitals in England, Wales and Northern Ireland are not being managed fully in accordance with international evidence-based guidelines. In comparison with earlier UK studies, the use of echocardiography and ACE-I and β-blockers has increased, and length of stay reduced. Only a minority of patients are seen, or followed up, by a specialist service. Women seem to be less well managed against recommended guidelines. Significant and sustained effort is required to address gender inequalities in the provision of heart failure care.

Statistics from Altmetric.com

Footnotes

  • Competing interests: None.

  • Ethics approval: Not required for this survey using anonymous data.

  • ED Nicol was responsible for the manuscript preparation; B Fittall for survey design and data collection; M Roughton for statistical analysis; JGF Cleland and H Dargie for manuscript advice; and MR Cowie for survey design, manuscript advice and sponsor.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.